Related Experiment Video
Updated: Jun 24, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Decreased nucleoside transport and hENT1 transporter expression in beta-thalassemia major
Arwa Lufti Al-Massaeid1, James D Craik
1Department of Biochemistry, Faculty of Medicine, Health Sciences Center, Kuwait University, Kuwait.
Objective:
This study investigated nucleoside transport activity and transporter polypeptide expression in erythrocytes from beta-thalassemia major patients to determine if inhibition of transport activity is a sensitive indicator of oxidative membrane damage.
Materials And Methods:
Blood samples were obtained from 54 patients, diagnosed as having beta-thalassemia major prior to therapeutic transfusion, and 20 normal subjects. Uptake of (3)H-uridine into washed erythrocytes was measured at room temperature using short incubation periods (5 s) and a rapid inhibitor oil stop protocol. Erythrocyte membranes were analyzed by SDS-PAGE and nucleoside (hENT1) and glucose (GLUT-1) transporter polypeptides quantitated on immunoblots.
Results:
Uridine uptake was significantly lower in beta-thalassemic cells than in normal erythrocytes (20.03 +/- 1.08 pmol/10(8) cells/ 5 s, mean +/- SEM, n = 31, vs. 31.15 +/- 1.21 pmol/10(8) cells/5 s, n = 20; p < 0.0001). Expression of hENT1 was significantly lower in beta-thalassemic cells (23.90 +/- 1.01 arbitrary units, n = 54) than in controls (101.20 +/- 2.43 arbitrary units, n = 20; p < 0.001) but expression of GLUT-1 was not changed appreciably (101.80 +/- 2.43 arbitrary units, n = 54, for thalassemic cells; 102.60 +/- 3.02 arbitrary units, n = 20, for control cells; p = 0.87).
Conclusions:
Erythrocytes from beta-thalassemia major patients showed decreased uridine transport which was associated with decreased nucleoside transporter expression. The process(es) mediating a selective decrease in hENT1 polypeptides in beta-thalassemia major was/were not determined.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
